Press "Enter" to skip to content

New patent for Nalpropion drug CONTRAVE

1
Copyright © DrugPatentWatch. Originally published at New patent for Nalpropion drug CONTRAVE

Annual Drug Patent Expirations for CONTRAVE
Annual Drug Patent Expirations for CONTRAVE

Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from three suppliers. There are twelve patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for CONTRAVE.

This drug has one hundred and seventy-three patent family members in thirty-four countries.

The generic ingredient in CONTRAVE is bupropion hydrochloride; naltrexone hydrochloride. Three suppliers are listed for this compound. Additional details are available on the bupropion hydrochloride; naltrexone hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Nalpropion drug CONTRAVE
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions